Drug Utilisation Review (DUR) of the Third Generation Cephalosporins
- 1 September 1995
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 50 (3) , 423-439
- https://doi.org/10.2165/00003495-199550030-00002
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Pharmacoeconomic Studies on AntibioticsPharmacoEconomics, 1994
- Oral CiprofloxacinPharmacoEconomics, 1993
- Considerations in Dosage Selection for Third Generation CephalosporinsClinical Pharmacokinetics, 1992
- Comparison of the efficacy and adverse effect profile of cefotaxime and ceftriaxone in ICU patients with susceptible infectionsDiagnostic Microbiology and Infectious Disease, 1992
- A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infectionsDiagnostic Microbiology and Infectious Disease, 1992
- Comparison of cefotaxime with ceftriaxone given intramuscularly 12-hourly for community-acquired pneumoniaDiagnostic Microbiology and Infectious Disease, 1992
- Current status of bacterial resistance to third-generation cephalosporinsDiagnostic Microbiology and Infectious Disease, 1992
- Evaluating the cost-effectiveness of treatment with third-generation cephalosporinsDiagnostic Microbiology and Infectious Disease, 1992
- A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in childrenThe Journal of Pediatrics, 1985
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976